tiprankstipranks
Trending News
More News >
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Belite Bio, Inc. ADR (BLTE) Stock Statistics & Valuation Metrics

Compare
28 Followers

Total Valuation

Belite Bio, Inc. ADR has a market cap or net worth of $1.87B. The enterprise value is $1.33B.
Market Cap$1.87B
Enterprise Value$1.33B

Share Statistics

Belite Bio, Inc. ADR has 32.28M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32.28M
Owned by Insiders7.30%
Owned by Instutions0.53%

Financial Efficiency

Belite Bio, Inc. ADR’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee$0
Profits Per Employee-$1,684,120
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00

Valuation Ratios

The current PE Ratio of Belite Bio, Inc. ADR is -38.46. Belite Bio, Inc. ADR’s PEG ratio is -0.42.
PE Ratio-38.46
PS Ratio0.00
PB Ratio13.45
Price to Fair Value13.45
Price to FCF-40.69
Price to Operating Cash Flow-40.78
PEG Ratio-0.42

Income Statement

In the last 12 months, Belite Bio, Inc. ADR had revenue of $0.00 and earned -$42.10M in profits. Earnings per share was -$1.49.
Revenue$0.00
Gross Profit$0.00
Operating Income-$43.59M
Pretax Income-$42.09M
Net Income-$42.10M
EBITDA-43.48M
Earnings Per Share (EPS)-1.49

Cash Flow

In the last 12 months, operating cash flow was $0.00 and capital expenditures $0.00, giving a free cash flow of $0.00 billion.
Operating Cash Flow$0.00
Free Cash Flow$0.00
Free Cash Flow per Share$0.00

Dividends & Yields

Belite Bio, Inc. ADR pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.72
52-Week Price Change64.10%
50-Day Moving Average60.99
200-Day Moving Average58.15
Relative Strength Index (RSI)44.30
Average Volume (3m)51.13K

Important Dates

Belite Bio, Inc. ADR upcoming earnings date is May 7, 2025, After Close.
Last Earnings DateMar 17, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date

Financial Position

Belite Bio, Inc. ADR as a current ratio of 24.76, with Debt / Equity ratio of <0.01
Current Ratio24.76
Quick Ratio24.76
Debt to Market Cap0.00
Net Debt to EBITDA
Interest Coverage Ratio-1.27K

Taxes

In the past 12 months, Belite Bio, Inc. ADR has paid $9.00K in taxes.
Income Tax$9.00K
Effective Tax Rate-0.03%

Enterprise Valuation

Belite Bio, Inc. ADR EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Belite Bio, Inc. ADR has $95.50M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$95.50M billion.
Cash & Marketable Securities$95.50M
Total Debt$0.00
Net Cash-$95.50M
Net Cash Per Share-$2.96
Tangible Book Value Per Share$3.28

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%

Analyst Forecast

The average price target for Belite Bio, Inc. ADR is $96.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$96.67
Price Target Upside64.94%
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score6
AI Score41
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis